Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: A randomised phase II study

European Journal of Cancer

Volumn 49, Issue 5, 2013, Pages 1058-1064

  Bar Sela, Gil ^a   Wollner, Mira ^a   Hammer, Liat ^a   Agbarya, Abed ^a   Dudnik, Elizabeth ^a   Haim, Nissim ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chemotherapy; Iscador; Lung cancer; Mistletoe; Side effects

Indexed keywords

CARBOPLATIN; CYANOCOBALAMIN; DEXAMETHASONE; FOLIC ACID; GEMCITABINE; ISCADOR Q; PEMETREXED; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG; VISCUM ALBUM EXTRACT;

ADULT; ADVANCED CANCER; AGED; ALTERNATIVE MEDICINE; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED ANEMIA; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSPNEA; FEBRILE NEUTROPENIA; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INJECTION SITE REACTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STOMATITIS; THROMBOCYTOPENIA; VISCUM ALBUM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MISTLETOE; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 84874936058     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.11.007     Document Type: Article

References (24)

1. E. Rapp, J.L. Pater, and A. Willan Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial J Clin Oncol 6 1988 633 641
2. S. Ramalingam, and C.P. Belani State-of-the-art chemotherapy for advanced non-small cell lung cancer Semin Oncol 31 2004 68 74
3. T. Le Chevalier, G. Scagliotti, and R. Natale Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes Lung Cancer 47 2005 69 80
4. G.V. Scagliotti, P. Parikh, and J. von Pawel Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J Clin Oncol 26 2008 3543 3551
5. A. Molassiotis, P. Fernadez-Ortega, and D. Pud Use of complementary and alternative medicine in cancer patients: a European survey Ann Oncol 16 2005 655 663
6. G. Bar-Sela White-berry mistletoe (Viscum album L.) as complementary treatment in cancer: does it help? Eur J Integr Med 3 2011 e55 e62
7. M.A. Horneber, G. Bueschel, and R. Huber Mistletoe therapy in oncology Cochrane Database Syst Rev 16 2008 CD003297
8. U. Dold, L. Edler, and H.Ch. Mäurer Adjuvant cancer therapy in advanced non-small cell bronchial cancer: multicentric controlled studies to test the efficacy of iscador and polyerga 1991 Georg Thieme Verlag Stuttgart, Germany
9. P.J. Mansky, D.B. Wallerstedt, and T. Sannes NCCAM/NCI phase I study of mistletoe extract and gemcitabine in patients with advanced solid tumors J Clin Oncol 28 Suppl. 15 2010 A 2559 Abstract
10. P. Therasse, S.G. Arbuck, and E.A. Eisenhaur New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
11. Multinational Association of Supportive Care in Cancer. < http://www.mascc.org >.
12. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). < http://ctep.cancer.gov/reporting/ctc.html >.
13. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
14. B. Bergman, N.K. Aaronson, and S. Ahmedzai The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life Eur J Cancer 30 1994 635 642
15. H.J. Gabius, F. Darro, and M. Remmelink Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts Cancer Invest 19 2001 114 126
16. A. Wiedłocha, K. Sandvig, and H. Walzel Internalization and action of an immunotoxin containing mistletoe lectin A-chain Cancer Res 51 1991 916 920
17. J. Tabiasco, F. Pont, J.J. Fournié, and A. Vercellone Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity Eur J Biochem 269 2002 2591 2600
18. A. Coulon, E. Berkane, and A.M. Sautereau Modes of membrane interaction of a natural cysteine-rich peptide: viscotoxin A3 Biochim Biophys Acta 1559 2002 145 159
19. J. Doehmer, and J. Eisenbraun Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities Phytother Res 26 2012 11 17
20. B.K. Piao, Y.X. Wang, and G.R. Xie Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial Anticancer Res 24 2004 303 310
21. E. Laack, N. Dickgreber, and T. Müller German and Swiss Lung Cancer Study Group. Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group J Clin Oncol 22 2004 2348 2356
22. G.S. Kienle, and H. Kiene Review article: influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies Integr Cancer Ther 9 2010 142 157
23. M.K. Steuer-Vogt, V. Bonkowsky, and P. Ambrosch The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial Eur J Cancer 37 2001 23 31
24. T. Ostermann, C. Raak, and A. Büssing Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review BMC Cancer 9 2009 451